Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

September 28, 2017

NEW ENGLAND CARPENTERS HEALTH BENEFITS FUND v. CELGENE CORPORATION

Track this case

Case Number:

2:17-cv-07637

Court:

New Jersey

Nature of Suit:

Anti-Trust

Multi Party Litigation:

Class Action

Judge:

Madeline Cox Arleo

Firms

Companies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. September 29, 2017

    Celgene Hit With Expansive Antitrust Suit Over Thalomid

    A health fund hit Celgene Corp. with a proposed class action Thursday in New Jersey federal court over the company's alleged anti-competitive behavior meant to keep its monopoly on the drugs Thalomid and Revlimid, including abusing a drug safety protocol, fraudulently obtaining patents and filing sham patent suits.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login